Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-20-056160)

Filing Details

Accession Number:: 0001104659-20-056160
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-05-04 15:25:32
Reporting Period:: 2020-04-30

Accepted Time:: 2020-05-04 15:25:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1173281	Neubase Therapeutics Inc.	NBSE	Pharmaceutical Preparations (2834)	465622433

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1774588	A Dietrich Stephan	C/O Neubase Therapeutics, Inc. 700 Technology Drive, Third Floor Pittsburgh PA 15219	President And Ceo	Yes	Yes	Yes	No
1783932	Lipizzaner Llc	C/O Neubase Therapeutics, Inc. 700 Technology Drive, Third Floor Pittsburgh DE 15219		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-04-30	10,000	$6.00	10,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,547,639	Indirect	See footnote

Footnotes

Shares held by Dietrich Stephan as a tenant by the entirety with his spouse.
Shares held directly by Lipizzaner LLC, of which Dr. Stephan is the sole member.